GATA3 differential expression in neuroblastoma and nephroblastoma

GATA3 differential expression in neuroblastoma and nephroblastoma We have read with great interest the report by Wiles et al, published in Cancer Cytopathology, about the immunohistochemical expression of the GATA3 antibody in cytological material from neuroblastomas. They evaluated GATA3 immunohistochemical expression in neuroblastoma cytology and/or biopsy samples, and diffuse nuclear positivity was found in all 30 specimens studied. Each sample revealed either strong (n = 26) or moderate nuclear staining (n = 4) in more than 75% of neuroblastoma cells, regardless of the presence or lack of stromata, necrosis, or differentiation.GATA3 is a relatively recent marker useful for diagnosing tumors of various epithelial and nonepithelial origins such as mammary tumors, urothelial tumors, renal tumors, germ cell tumors, mesotheliomas, and paragangliomas. Moreover, it is usually negative in round cell sarcomas. In contrast, little is known about GATA3 expression in blastemal or other small round cell pediatric tumors. Nonaka et al reported the presence of diffuse GATA3 expression in the neuroblastoma family of tumors and a lack of expression in other small round cell tumors.The distinction between neuroblastomas and nephroblastomas may be delicate because the clinical and radiological presentation may be overlapping. Moreover, we have previously encountered important difficulties in the cytological differential diagnosis between poorly differentiated neuroblastomas http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Cytopathology Wiley

GATA3 differential expression in neuroblastoma and nephroblastoma

Loading next page...
 
/lp/wiley/gata3-differential-expression-in-neuroblastoma-and-nephroblastoma-8MUJMUnt44
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 American Cancer Society
ISSN
1934-662X
eISSN
1934-6638
D.O.I.
10.1002/cncy.21952
Publisher site
See Article on Publisher Site

Abstract

We have read with great interest the report by Wiles et al, published in Cancer Cytopathology, about the immunohistochemical expression of the GATA3 antibody in cytological material from neuroblastomas. They evaluated GATA3 immunohistochemical expression in neuroblastoma cytology and/or biopsy samples, and diffuse nuclear positivity was found in all 30 specimens studied. Each sample revealed either strong (n = 26) or moderate nuclear staining (n = 4) in more than 75% of neuroblastoma cells, regardless of the presence or lack of stromata, necrosis, or differentiation.GATA3 is a relatively recent marker useful for diagnosing tumors of various epithelial and nonepithelial origins such as mammary tumors, urothelial tumors, renal tumors, germ cell tumors, mesotheliomas, and paragangliomas. Moreover, it is usually negative in round cell sarcomas. In contrast, little is known about GATA3 expression in blastemal or other small round cell pediatric tumors. Nonaka et al reported the presence of diffuse GATA3 expression in the neuroblastoma family of tumors and a lack of expression in other small round cell tumors.The distinction between neuroblastomas and nephroblastomas may be delicate because the clinical and radiological presentation may be overlapping. Moreover, we have previously encountered important difficulties in the cytological differential diagnosis between poorly differentiated neuroblastomas

Journal

Cancer CytopathologyWiley

Published: Jan 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off